Park Se-Young, Lee Sun Kyoung, Lim Mihwa, Kim Bomi, Hwang Byeong-Oh, Cho Eunae Sandra, Zhang Xianglan, Chun Kyung-Soo, Chung Won-Yoon, Song Na-Young
Department of Applied Life Science, The Graduate School, Yonsei University, Seoul 03722, Republic of Korea.
BK21 Four Project, Yonsei University College of Dentistry, Seoul 03722, Republic of Korea.
Biomol Ther (Seoul). 2022 May 1;30(3):284-290. doi: 10.4062/biomolther.2021.167.
Oral squamous cell carcinoma (OSCC) is mostly diagnosed at an advanced stage, with local and/or distal metastasis. Thus, locoregional and/or local control of the primary tumor is crucial for a better prognosis in patients with OSCC. Platelets have long been considered major players in cancer metastasis. Traditional antiplatelet agents, such as aspirin, are thought to be potential chemotherapeutics, but they need to be used with caution because of the increased bleeding risk. Podoplanin (PDPN)-expressing cancer cells can activate platelets and promote OSCC metastasis. However, the reciprocal effect of platelets on PDPN expression in OSCC has not been investigated. In this study, we found that direct contact with platelets upregulated PDPN and integrin β1 at the protein level and promoted invasiveness of human OSCC Ca9.22 cells that express low levels of PDPN. In another human OSCC HSC3 cell line that express PDPN at an abundant level, silencing of the gene reduced cell invasiveness. Analysis of the public database further supported the co-expression of PDPN and integrin β1 and their increased expression in metastatic tissues compared to normal and tumor tissues of the oral cavity. Taken together, these data suggest that PDPN is a potential target to regulate platelet-tumor interaction and metastasis for OSCC treatment, which can overcome the limitations of traditional antiplatelet drugs.
口腔鳞状细胞癌(OSCC)大多在晚期被诊断出来,伴有局部和/或远处转移。因此,对原发性肿瘤进行局部区域和/或局部控制对于改善OSCC患者的预后至关重要。长期以来,血小板一直被认为是癌症转移的主要参与者。传统的抗血小板药物,如阿司匹林,被认为是潜在的化疗药物,但由于出血风险增加,使用时需要谨慎。表达血小板膜蛋白(PDPN)的癌细胞可以激活血小板并促进OSCC转移。然而,血小板对OSCC中PDPN表达的反向作用尚未得到研究。在本研究中,我们发现与血小板直接接触会在蛋白质水平上上调PDPN和整合素β1,并促进低水平表达PDPN的人OSCC Ca9.22细胞的侵袭性。在另一种大量表达PDPN的人OSCC HSC3细胞系中,该基因的沉默降低了细胞侵袭性。对公共数据库的分析进一步支持了PDPN和整合素β1的共表达,以及它们在转移组织中的表达高于口腔正常组织和肿瘤组织。综上所述,这些数据表明PDPN是调节血小板-肿瘤相互作用和转移以治疗OSCC的潜在靶点,这可以克服传统抗血小板药物的局限性。